Protein arginine methylation: from enigmatic functions to therapeutic targeting

Q Wu, M Schapira, CH Arrowsmith… - Nature reviews Drug …, 2021 - nature.com
Protein arginine methyltransferases (PRMTs) are emerging as attractive therapeutic targets.
PRMTs regulate transcription, splicing, RNA biology, the DNA damage response and cell …

Protein arginine methyltransferases: promising targets for cancer therapy

JW Hwang, Y Cho, GU Bae, SN Kim… - Experimental & molecular …, 2021 - nature.com
Protein methylation, a post-translational modification (PTM), is observed in a wide variety of
cell types from prokaryotes to eukaryotes. With recent and rapid advancements in epigenetic …

[HTML][HTML] Arginine methylation: the coming of age

RS Blanc, S Richard - Molecular cell, 2017 - cell.com
Arginine methylation is a common post-translational modification functioning as an
epigenetic regulator of transcription and playing key roles in pre-mRNA splicing, DNA …

The NFIB/CARM1 partnership is a driver in preclinical models of small cell lung cancer

G Gao, S Hausmann, NM Flores, AM Benitez… - Nature …, 2023 - nature.com
The coactivator associated arginine methyltransferase (CARM1) promotes transcription, as
its name implies. It does so by modifying histones and chromatin bound proteins. We …

PIK3CA mutations confer resistance to first-line chemotherapy in colorectal cancer

Q Wang, Y Shi, K Zhou, L Wang, Z Yan, Y Liu… - Cell death & …, 2018 - nature.com
Chemotherapy represents an important treatment option for colorectal cancer (CRC), but
only half of the patients benefit from these regimens. We explored the potential predicting …

Cellular consequences of arginine methylation

BM Lorton, D Shechter - Cellular and Molecular Life Sciences, 2019 - Springer
Arginine methylation is a ubiquitous post-translational modification. Three predominant
types of arginine-guanidino methylation occur in Eukarya: mono (Rme1/MMA), symmetric …

Arginine methylation‐dependent LSD1 stability promotes invasion and metastasis of breast cancer

J Liu, J Feng, L Li, L Lin, J Ji, C Lin, L Liu, N Zhang… - EMBO …, 2020 - embopress.org
Abstract Histone lysine demethylase 1 (LSD 1), the first identified histone demethylase, is
overexpressed in multiple tumor types, including breast cancer. However, the mechanisms …

Global mapping of CARM1 substrates defines enzyme specificity and substrate recognition

E Shishkova, H Zeng, F Liu, NW Kwiecien… - Nature …, 2017 - nature.com
Protein arginine methyltransferases (PRMTs) introduce arginine methylation, a post-
translational modification with the increasingly eminent role in normal physiology and …

[HTML][HTML] Protein arginine methylation/demethylation and cancer

C Poulard, L Corbo, M Le Romancer - Oncotarget, 2016 - ncbi.nlm.nih.gov
Protein arginine methylation is a common post-translational modification involved in
numerous cellular processes including transcription, DNA repair, mRNA splicing and signal …

[HTML][HTML] TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma

K Nakayama, MM Szewczyk, C dela Sena, H Wu… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Abstract Protein arginine methyltransferase (PRMT) 4 (also known as coactivator-associated
arginine methyltransferase 1; CARM1) is involved in a variety of biological processes and is …